Richter Gedeon Vegyeszeti Gyar Rt

Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.

Egis Gyogyszergyar

Egis Gyogyszergyar Rt.

Alkaloida Vegyeszeti Gyar

Biogal Gyogyszergyar

Biorex Kutato Es Fejleszto Rt

Biorex Research & Development Co.

Laszlo Jaszlits

Istvan Elekes

Gyorgy Cseh

Endre Kasztreiner

Peter Matyus

Gyorgy Rabloczky

Laszlo Tardos

Sandor Elek

Istvan Polgari

Geza Szilagyi

Andras Varro

Edit Kosa

Ilona Bodi

Judit Kosary

Maria Kuhar Nee Kurthy

Andrea Jednakovits

Katalin Biro

Agnes Kenessey

Zsuzsa Huszti

Nandor Makk

Mihaly Barabas

Eszter Diesler

Pal Tolnay

Gyongyi Nagy Nee Csokas

Klara Czako

Marton Fekete

Gyula Horvath

Katalin Szemeredi

Laszlo Vereczkey

Jozsef Borsi

Istvan Pallagi

Laszlo Sebestyen

Melinda Gal

Eva Gal

Eva Bozo

Agnes Papp

Erzsebet Zara

Erzsebet Radvanyi Nee Hegedus

Judit Sarossy Nee Kincsesy

Ildiko Varga

Aniko Tegdes

Aniko Miklos Nee Kovacs

Endre Tihanyi

Gyorgy Rablocsky

Judit Kincsessy

Laszlo Kaufer

Laszlo Szam

Ildiko Pribusz Nee Rapp

Istvan Erczi

Sarolta Vegvari Nee Gyurki

ZSuzanne Lang Nee Rihmer

Laszlo Czollner

Laszlo Szatmary

Jeno Marosfalvi

Andras Divald

Szilagyi Geza

Ilona Kovacs, Nee Szabo

Istvanne Udvardy-Nagy

Istvanne Udvardy Nagy

Erzsebet Radvanyne

Luca Levay

Gvorgy Schmidt

Aniko Miklos

Andrea Jednakovics

Antal Simai

Gyorgy Mathe

Adrina Kiss

Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions

Hydroximic acid derivatives, pharmaceutical compositions containing

The invention relates to racemic or optically active 1,3,4-benzotriazepin-5(4H)-one derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said compounds for the treatment of diseases and for the preparation of pharmaceutical compositions containing the said compounds as active agent. The new compounds according to the invention correspond to the general formula (I), ##STR1## wherein R.sup.1 represents hydrogen or straight or branched chain C.sub.1-4 alkyl optionally carrying a pyridyl or a phenyl substituent;

1,3,4-benzotraizepin-5(4H)-one derivatives and process for the

Racemic or optically active new 3(2H)-pyridazinone derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said 3(2H)-pyridazinone derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The new 3(2H)-pyridazinone derivatives according to the invention correspond to the general formula (I), ##STR1##

3(2H)-pyridazinone derivatives and process for the preparation thereof

The invention relates to new substituted dihydropyridine derivatives of the general formula (I), ##STR1## wherein R.sup.1 and R.sup.6 are as defined herein after, the racemic and optically active variants as well as mixtures thereof, furthermore the acid addition salts of these compounds, pharmaceutical compositions containing the same and a process for the preparation thereof. The compounds of the general formula (I) can be advantageously applied for the treatment of pathologically severe hypertensions, their toxicity is low and they possess an advantageous therapeutic index.

Novel dihydropyridines having calcium antagonistic and antihypertensive

The invention relates to novel 3(2H)-pyridazinone-derivatives of the general formula (I), pharmaceutical compositions containing them and process for their preparation. In the general formula (I) ##STR1## stands for an ethyl or propyl group substituted by a terminal halogen atom or a hydroxyl or NR.sup.1 R.sup.2 group, wherein

3(2H)-pyridazinones and pharmaceutical compositions thereof

The invention relates to novel pyrimido [5,4-b][1,4]oxazine derivatives of the formula (I), and the acid addition salts thereof, pharmaceutical compositions containing them and a process for their preparation. In the formula (I) ##STR1## wherein R.sup.1 stands for a C.sub.1-4 alkyl group;

Pyrimido[5,4-B][1,4]oxazine derivatives and pharmaceutical compositions

The invention relates to new aminoguanidine derivatives of the general formula (I), ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 each represent hydrogen or halogen atom, C.sub.1-4 alkyl, nitro, trifluoromethyl or C.sub.1-4 alkoxy group,

Aminoguanidine compounds, their compositions and pharmaceutical uses

Pyridazinylhydrazones capable of lowering blood pressure have the formula ##STR1## wherein R.sup.1 is hydrogen, chlorine, alkyl having from 1 to 4 carbon atoms, methoxy, hydroxyl, carbamoyl or cyano;

Novel pyridazinylhydrazones and method of administering same

Pyridazinylhydrazones capable of lowering blood pressure having the formula ##STR1## wherein R.sup.1 is hydrogen, chlorine, alkyl having from 1 to 4 carbon atoms, methoxy, hydroxyl, carbamoyl or cyano;

Morpholino pyridazinylhydrazones

3-(1-Pyrazolyl)-pyridazine derivatives of the formula I, or pharmaceutically acceptable acid addition salts thereof, which decrease high blood pressure and inhibit catabolism or prostaglandins, ##STR1## wherein R.sup.1 is hydrogen or C.sub.1-4 alkyl,

3-(1-Pyrazolyl)-pyridazine derivatives

The invention relates to compounds of general formula ##STR1## wherein R.sup.1 stands for a hydrogen atom or a C.sub.1-6 alkyl-, a C.sub.2-4 hydroxyalkyl, a C.sub.3-6 cycloalkyl or a phenyl group,

3-(1-Pyrazolyl)-pyridazine derivatives and hypotensive compositions

Growing community of inventors

Budapest, Hungary

Laszlo Jaszlits